Icon boosts its hybrid clinical trial and site support services with the acquisition of Symphony Clinical Research, a provider of in-home and alternate site services.
Pepticom’s technology aims to ‘vastly reduce’ risk of failure in peptide drug candidates’ discovery and development, by utilizing artificial intelligence models.
GE Healthcare opens lab space to provide developers with access to protein and cell analysis technologies to encourage networking and partnering on R&D services.
SignalPath announced the closing of its Series B funding round to support the expansion of its software platform, which facilitates clinical trials management.
Early dialogue with patients is ‘critical’ to design efficient clinical development programs for ATMPs and avoid ‘data gaps’, an executive from ARM says.
The research models and services provider has acquired a company that specializes in tissue collections, and hematology, and immunology cell isolations to help meet its ‘ever-increasing’ client needs.
Alkermes to work collaboratively with the Fred Hutchinson Cancer Research Center on the clinical development of a drug candidate as a combination treatment alongside Keytruda.
In the company’s latest partnership, TrialSpark has partnered with Limbix to design and implement a clinical trial for a digital therapeutic for adolescent depression.
dMed Biopharmaceutical recently raised approximately $50m in a Series B financing to further expand the CRO’s operations after launching three years ago.
phaseUP is a new life sciences leadership firm that is looking to help pharma, biotech, and CROs build cohesive and collaborative teams – as the success or failure of a clinical development program depends on the people, says company founder.
Sponsors committed to standardizing data can benefit from ‘more than improved efficiency,’ says YPrime VP, as the company expands its eClinical portfolio to include data standards, clinical analytics and eCOA consulting services.
Yourway sets up a new EU-based location to provide storage and distribution services, including secondary packaging capabilities, as Brexit uncertainties abound.
